📣 VC round data is live. Check it out!

Medibank Valuation Multiples

Discover revenue and EBITDA valuation multiples for Medibank and similar public comparables like ICICI Lombard General, Old Republic International, Primerica, Clal Insurance and more.

Medibank Overview

About Medibank

Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.


Founded

1997

HQ

Australia

Employees

3.6K

Financials (LTM)

Revenue: $6B
EBITDA: $601M

EV

$9B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Medibank Financials

Medibank reported last 12-month revenue of $6B and EBITDA of $601M.

In the same LTM period, Medibank generated $621M in gross profit, $601M in EBITDA, and $441M in net income.

Revenue (LTM)


Medibank P&L

In the most recent fiscal year, Medibank reported revenue of $6B and EBITDA of $488M.

Medibank is profitable as of last fiscal year, with EBITDA margin of 8% and net margin of 6%.

See analyst estimates for Medibank
LTMLast FY202320242025202620272028
Revenue$6B$6B$6B$6B$6B
Gross Profit$621M——$1B$873M
Gross Margin10%——19%14%
EBITDA$601M$488M—$488M$553M
EBITDA Margin9%8%—8%9%
EBIT Margin9%8%—9%9%
Net Profit$441M$363M$364M$360M$411M
Net Margin7%6%6%6%6%

Financial data powered by Morningstar, Inc.

Medibank Stock Performance

Medibank has current market cap of $9B, and enterprise value of $9B.

Market Cap Evolution


Medibank's stock price is $3.28.

Medibank share price decreased by 1.9% in the last 30 days, and by 3.2% in the last year.

Medibank has an EPS (earnings per share) of $0.13.

See more trading valuation data for Medibank
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9B$9B-0.7%-1.9%4.4%-3.2%$0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Medibank Valuation Multiples

Medibank trades at 1.4x EV/Revenue multiple, and 14.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Medibank

EV / Revenue (LTM)


Medibank Financial Valuation Multiples

As of May 13, 2026, Medibank has market cap of $9B and EV of $9B.

Medibank has a P/E ratio of 20.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.6x1.5x1.4x
EV/EBITDA14.8x18.3x—18.3x16.1x
EV/EBIT15.2x17.4x—17.4x16.0x
EV/Gross Profit14.4x——8.0x10.2x
P/E20.5x24.9x24.9x25.1x22.0x
EV/FCF21.3x30.9x25.8x21.9x26.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Medibank Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Medibank Margins & Growth Rates

Medibank grew revenue by 6% and EBITDA by 27% in the last fiscal year.

In the most recent fiscal year, Medibank reported EBITDA margin of 8% and net margin of 6%.

See estimated margins and future growth rates for Medibank

Medibank Margins

Last FY202420252026202720282029
Gross Margin—19%14%10%
EBITDA Margin8%8%9%9%
EBIT Margin8%9%9%9%
Net Margin6%6%6%7%
FCF Margin5%7%5%9%

Medibank Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%7%6%6%
Gross Profit Growth——(21%)(25%)
EBITDA Growth27%—13%16%
EBIT Growth17%—8%12%
Net Profit Growth26%(1%)14%17%
FCF Growth52%18%(18%)89%

Data powered by FactSet, Inc. and Morningstar, Inc.

Medibank Operational KPIs

Medibank's revenue per employee in the last FY averaged $1.7M.

Medibank's Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medibank's Rule of X is 24% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Medibank
LTMLast FY202320242025202620272028
Rule of 4016%15%———
Bessemer Rule of X26%24%———
Revenue per Employee—$1.7M———
S&M Expenses to Revenue—2%2%2%2%
G&A Expenses to Revenue0%10%9%10%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Medibank Competitors

Medibank competitors include ICICI Lombard General, Old Republic International, Primerica, Clal Insurance, ICICI Prudential Life, Migdal Group, Vienna Insurance Group, Beazley, Standard Life and Jackson Financial.

Most Medibank public comparables operate across Insurance Carriers.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
ICICI Lombard General2.8x2.8x68.0x68.6x
Old Republic International1.2x1.2x——
Primerica3.0x2.9x——
Clal Insurance1.4x———
ICICI Prudential Life1.2x1.2x——
Migdal Group(0.2x)———
Vienna Insurance Group0.6x0.6x——
Beazley1.6x1.5x7.8x8.5x

This data is available for Pro users. Sign up to see all Medibank competitors and their valuation data.

Start Free Trial

Medibank M&A Activity

Medibank has acquired 1 company to date.

Last acquisition by Medibank was on March 7th 2025. Medibank acquired Medinet for $7M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Medibank

Medinet
Description
Medinet is a Melbourne-headquartered health technology firm specializing in telehealth solutions for general practitioners in Australia. Its flagship MyPractice app facilitates video, audio, and chat consultations between doctors and patients. The platform generates digital referrals to specialists, pathology labs, and imaging centers while delivering patient information directly to mobile devices. Customizable for individual practices, MyPractice enables sharing of educational materials and practice updates, streamlining administrative tasks for healthcare providers across the country.
HQ CountryAustralia
HQ City
Sydney
Deal Date7 Mar 2025
Valuation$7M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Medibank acquisitions and their M&A valuation multiples.

Start Free Trial

Medibank Investment Activity

Medibank has invested in 2 companies to date.

Latest investment by Medibank was on March 17th 2022. Medibank invested in Medinet in their $10M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Medibank

Medinet
Myhealth Medical Group
Description
Medinet is a Melbourne-headquartered health technology firm specializing in telehealth solutions for general practitioners in Australia. Its flagship MyPractice app facilitates video, audio, and chat consultations between doctors and patients. The platform generates digital referrals to specialists, pathology labs, and imaging centers while delivering patient information directly to mobile devices. Customizable for individual practices, MyPractice enables sharing of educational materials and practice updates, streamlining administrative tasks for healthcare providers across the country.
Myhealth Medical Group is a Sydney-based operator of primary care clinics throughout Australia. The group manages over 40 medical centers offering general practice, women's health, skin checks, and chronic disease management. Myhealth Medical Group integrates telehealth services and bulk-billing options across New South Wales, Victoria, and Queensland.
HQ CountryAustraliaAustralia
HQ City
Sydney
Sydney
Deal Date17 Mar 20225 Feb 2021
RoundSeries AStrategic investment
Raised$10M$49M
InvestorsMedibankMedibank
Valuationundisclosed$134M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Medibank investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Medibank

When was Medibank founded?Medibank was founded in 1997.
Where is Medibank headquartered?Medibank is headquartered in Australia.
How many employees does Medibank have?As of today, Medibank has over 3K employees.
Who is the CEO of Medibank?Medibank's CEO is David Koczkar.
Is Medibank publicly listed?Yes, Medibank is a public company listed on Australian Securities Exchange.
What is the stock symbol of Medibank?Medibank trades under MPL ticker.
When did Medibank go public?Medibank went public in 2014.
Who are competitors of Medibank?Medibank main competitors include ICICI Lombard General, Old Republic International, Primerica, Clal Insurance, ICICI Prudential Life, Migdal Group, Vienna Insurance Group, Beazley, Standard Life, Jackson Financial.
What is the current market cap of Medibank?Medibank's current market cap is $9B.
What is the current revenue of Medibank?Medibank's last 12 months revenue is $6B.
What is the current revenue growth of Medibank?Medibank revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Medibank?Current revenue multiple of Medibank is 1.4x.
Is Medibank profitable?Yes, Medibank is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Medibank?Medibank's last 12 months EBITDA is $601M.
What is Medibank's EBITDA margin?Medibank's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Medibank?Current EBITDA multiple of Medibank is 14.8x.
What is the current FCF of Medibank?Medibank's last 12 months FCF is $418M.
What is Medibank's FCF margin?Medibank's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Medibank?Current FCF multiple of Medibank is 21.3x.
How many companies Medibank has acquired to date?As of May 2026, Medibank has acquired 1 company.
What was the largest acquisition by Medibank?$7M acquisition of Medinet on 7th March 2025 was the largest M&A Medibank has done to date.
What companies Medibank acquired?Medibank acquired Medinet.
In how many companies Medibank has invested to date?As of May 2026, Medibank has invested in 2 companies.
What was the last Medibank investment?On 17th March 2022 Medibank invested in Medinet, participating in a $10M Series A round.
In what companies Medibank invested in?Medibank invested in Myhealth Medical Group and Medinet.

See public comps similar to Medibank

Lists including Medibank

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial